Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00227838 · ClinicalTrials.gov registry record · NA

Modifying Group Therapy for Bipolar Substance Abusers - 1

A NA study, sponsored by National Institute on Drug Abuse (NIDA).

Completed
Registry status
NA
Development phase
60
Enrollment target

NCT00227838: Completed NA study, sponsored by National Institute on Drug Abuse (NIDA).

NCT00227838 is a NA study that has completed, run by National Institute on Drug Abuse (NIDA). The registered enrollment target is 60 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00227838, a NA study, has completed, sponsored by National Institute on Drug Abuse (NIDA).

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target

Study Summary

The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 sessions in this trial, and is being conducted by front-line drug counselors, to test its effectiveness in a more community-based setting. The training has been expanded so that counselors without much psychopathology training or cognitive behavioral therapy experience can conduct IGT.

Interventions

  • BEHAVIORAL Behavior Therapy

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2003-07
Est. Completion 2005-08
Phase NA

What the finished NCT00227838 record still lists

NCT00227838 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (96% lower).

The record links to 0 conditions, and to 1 intervention - of which Behavior Therapy is the first listed.

NCT00227838 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT00227838 about?

NCT00227838 is a clinical study titled "Modifying Group Therapy for Bipolar Substance Abusers - 1". The purpose of this study is to modify Integrated Group Therapy (IGT), which is has been found successful for patients with bipolar disorder (BD) and substance use disorder(SUD), so that it can be more readily adopted by community drug abuse treatment programs. IGT is being reduced from 20 to 12 ses...

What is the current status of trial NCT00227838?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2003-07. Estimated completion is 2005-08.

What interventions are being tested in trial NCT00227838?

The interventions under investigation include: Behavior Therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT00227838?

This trial is sponsored by National Institute on Drug Abuse (NIDA), which has 335 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT00227838's enrollment target sits among peer trials

60 1164th of 2000 higher than 745 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00227838, the US trial registry maintained by the National Library of Medicine. NCT00227838 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.